Synthego

FromSynthego ([email protected])
Subject (61)Bridge the Gap Between RUO and the Clinic with New INDe sgRNA
Preheader (108)Discover Synthego's new IND-enabling sgRNA, designed for preclinical safety, toxicity, and efficacy studies.
Typography
sans
Colors
Text Analysis
Body Words201
Subject Words12
Body Emojis1
Subject Emojis
Media Analysis
Text Links7
Image Links4
Total Links11
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px1394 px
X-Spam Score-5.1
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEarly Morning

Bridge the Gap Between RUO and the Clinic with New INDe sgRNA

Discover Synthego's new IND-enabling sgRNA, designed for preclinical safety, toxicity, and efficacy studies.
Bridge the Gap Between RUO and the Clinic with New INDe sgRNA